Your Article Summary
Lundbeck to intensify focus on new products
Lundbeck, 07/06/09
In order to ensure a maximum commercial return on the company's highly promising late-stage pipeline, Lundbeck is setting up a new unit dedicated to completing the development and marketing of Lundbeck's new pharmaceuticals. H. Lundbeck A/S is intensifying its efforts to bring the company's new pharmaceuticals to market. Setting up a whole new unit, New Products, as of today, Lundbeck dedicates even more resources to the strategically important task of developing and commercialising the company's promising late-stage products.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Greater chances of cure for patients with HER2-positive early breast cancer when treated with one year of Herceptin
Roche, 12/14/09
Article Search
Sponsor


See Latest Articles


